婦人科関連 QOL/PRO 指標

QOL指標 : 
EHP-30
子宮内膜症の影響に関する評価尺度 

所有者:
Clinical Outcomes at Oxford
University Innovation

連絡先:
https://innovation.ox.ac.uk/outcome-measures/endometriosis-health-profile-ehp/             

目的:
子宮内膜症におけるHRQOLの測定

使用条件/手続き:
https://process.innovation.ox.ac.uk/clinicalから申請

書誌事項:
Jones G et al.,Obstet Gynecol 2001; 98 (2): 258–264
Jones G et al.,Qual Life Res. 2004 Apr;13(3):705-13
Khong SY et al.,Fertil Steril. 2010 Oct;94(5):1928-32.
Georgina Jones et al.,Human Rep.2006 21(10): 2686–2693

設問数:

30+23

QOL指標 : 
EHP-5
子宮内膜症の影響に関する評価尺度

所有者:
Clinical Outcomes at Oxford
University Innovation

連絡先:
https://innovation.ox.ac.uk/outcome-measures/endometriosis-health-profile-ehp/                  

目的:
子宮内膜症におけるHRQOLの測定

使用条件/手続き:
https://process.innovation.ox.ac.uk/clinicalから申請

書誌事項:
Jones G et al.,Qual Life Res. 2004 Apr;13(3):695-704.

設問数:
5

QOL指標:
MMAS

所有者:
バイエル薬品株式会社（日本語版に限る）

連絡先:
バイエル薬品（株）PICC アクセス＆パイプライン戦略推進
TEL: 03-6266-7737（東京支社代表）

目的:
過多月経患者のHRQOLを多面的に評価すること

使用条件/手続き:
日本語版MMAS は、バイエル薬品（株）主導の臨床研究(言語的バリデーション)において、聖路加国際病院 百枝幹雄 先生のご指導のもと開発され、知的財産権をバイエル薬品（株）が有しております。

・研究目的で日本語版MMAS の使用をご希望される場合
論文等の研究の成果物には必ず原著版 MMASの引用記載（下記のpublication 情報を含む）をお願いいたします。
Shaw RW, Brickley MR, Evans L, Edwards MJ. Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment. British Journal of Obstetrics and Gynaecology 1998; 105:1155-9.

・研究以外の目的で使用を希望される場合
原作者へ使用許諾のご確認をお願いいたします。

書誌事項:
Pattison et.al BJOG_2011;
118:1528–1531.

日本語版MMAS：概念同等性の確認および文章表現の適切性確認まで実施済であり、日本人での計量心理学的評価は未実施。

設問数:
6
4つの選択肢から回答選択

QOL指標:
SF-36v2
-acute version

所有者:
iHope International株式会社

連絡先:
https://www.sf-36.jp/index.html

目的:
HRQOLを測定するための、科学的で信頼性・妥当性を持つ尺度

使用条件/手続き:
左記リンクから使用登録申請（有料）

書誌事項:
N/A

設問数:
36

QOL指標:
SF-12v2/
SF-8

所有者:
同上

連絡先:
同上

目的:
SF-36から選択された12/8からなる短縮版

使用条件/手続き:
左記リンクから使用登録申請（有料）

書誌事項:
N/A

設問数:
12/8

QOL指標:
EQ-5D-5L/
EQ-5D-3L

所有者:
EuroQol Group

連絡先:
https://euroqol.org/eq-5d-registration-form/

目的:
評価やアロケーション、モニタリングなどの目的で様々な介入によるヘルスアウトカムを共通スケールで評価すること

使用条件/手続き:
Registration Form（左記リンク）から申請
研究目的の場合は無料、その他は要問い合わせ

書誌事項:
N/A

設問数:
5(5段階)とVAS
/5(3段階)とVAS

The official name of the questionnaire:
MDQ
Menstrual Distress
Questionnaire

Copyright owner:
Copyright owner: Copyright © 1968, 1991, 2000, 2010 Rudolf H. Moos, Center for Health Care Evaluation, Department of Psychiatry, Stanford University, Palo Alto,
California.

Contact information ( URL / Address / email, etc.):
Contact Information: Mind Garden, 855 Oak Grove Ave, Suite #215, Menlo Park,
CA 94025; (Phone 650-322-6300; FAX 650-322-6398; website is:
www.mindgarden.com; email is info@mindgarden.com

Target disease and the purpose of the questionnaire:
To assess menstrual cycle symptoms and disorders

Terms and conditions or limitation of use (URL or documents, etc.):
Terms and Conditions: All inquiries about the Menstrual Distress Questionnaire should be directed to the publisher, Mind Garden, whose address, website, and email contact is provided above.

Validation articles:
Validation articles: (1) Moos, R. (1968). The development of a Menstrual Distress Questionnaire. Psychosomatic Medicine, 30, 853-867. [Note. This is the original publication describing the development of the Menstrual Distress Questionnaire.] (2) Moos, R. (2010). Menstrual Distress Questionnaire manual (4th ed.). Menlo Park, CA: Mind Garden. [Note. This Manual contains information about the development, psychometric characteristics, and reliability of the Questionnaire, and provides information on about 300 studies that have applied the Questionnaire.]

Number of questions:
46

The official name of the questionnaire:
FSFI
Female Sexual Function Index

Copyright owner:
Copyright © 2000 Target Health. All rights reserved.

Contact information ( URL / Address / email, etc.):
Mapi Research Trust PROVIDE™ 27 rue de la Villette 69003 Lyon France Phone: +33 (0)4 72 13 66 66
URL: https://mapi-trust.org/

Target disease and the purpose of the questionnaire:
To measure female sexual arousal and other domains of sexual functioning in women. Therapeutic area:Female Urogenital Diseases and Pregnancy Complications

Terms and conditions or limitation of use (URL or documents, etc.):
Contact:Mapi Research Trust

Validation articles:
N/A

Number of questions:
N/A

The official name of the questionnaire:
KHQ
King's Health Questionnaire

Copyright owner:
KHQ © Linda Cardozo and Con Kelleher, 1997. All Rights Reserved.

Contact information ( URL / Address / email, etc.):
Mapi Research Trust PROVIDE™ 27 rue de la Villette 69003 Lyon France Phone: +33 (0)4 72 13 66 66
URL: https://mapi-trust.org/

Target disease and the purpose of the questionnaire:
To assess the impact of lower urinary tract symptoms including urinary incontinence on health related quality of life. Therapeutic area: Female Urogenital Diseases and Pregnancy Complications / Pathological Conditions, Signs and Symptoms / Male Urogenital Diseases

Terms and conditions or limitation of use (URL or documents, etc.):
Contact:Mapi Research Trust

Validation articles:
N/A

Number of questions:
N/A

The official name of the questionnaire:
MENQOL
Menopause-specific Quality of Life Questionnaire

Copyright owner:
Copyright © 2005 Sunnybrook Health Sciences Centre. All rights reserved.

Contact information ( URL / Address / email, etc.):
Mapi Research Trust PROVIDE™ 27 rue de la Villette 69003 Lyon France Phone: +33 (0)4 72 13 66 66
URL: https://mapi-trust.org/

Target disease and the purpose of the questionnaire:
To determine differences in quality of life between menopausal women and to measure changes in their quality of life over time. Therapeutic area: Female Urogenital Diseases and Pregnancy Complications / Reproductive and Urinary Physiological Phenomena

Terms and conditions or limitation of use (URL or documents, etc.):
Contact:Mapi Research Trust

Validation articles:
N/A

Number of questions:
N/A